Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.6300
-0.0011 (-0.17%)
At close: Feb 19, 2026, 4:00 PM EST
0.6301
+0.0001 (0.02%)
After-hours: Feb 19, 2026, 7:59 PM EST

Tenaya Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
136113221129782-
Market Cap Growth
63.98%-48.67%71.58%-83.56%--
Enterprise Value
9248105-5518-
Last Close Price
0.631.433.242.0118.95-
PB Ratio
1.241.221.580.532.81-
P/TBV Ratio
1.651.221.580.532.81-
Debt / Equity Ratio
0.140.150.090.060.06-
Net Debt / Equity Ratio
-0.54-0.51-0.66-0.78-0.85-0.92
Net Debt / EBITDA Ratio
0.510.450.751.593.373.53
Net Debt / FCF Ratio
0.610.520.891.512.742.84
Quick Ratio
4.263.854.607.7911.5425.50
Current Ratio
4.644.224.917.9911.7325.78
Return on Equity (ROE)
-96.44%-95.69%-64.83%-47.39%-34.80%-45.51%
Return on Assets (ROA)
-49.48%-49.90%-36.49%-26.47%-19.68%-26.13%
Return on Capital Employed (ROCE)
-105.90%-111.50%-88.80%-49.30%-24.90%-27.20%
Earnings Yield
-69.10%-98.10%-56.23%-96.15%-9.30%-
FCF Yield
-53.86%-80.79%-46.81%-97.23%-10.98%-
Buyback Yield / Dilution
-59.81%-14.96%-64.61%-152.75%-1724.33%-28.62%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q